Maria Lúcia Alves Pedroso

Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy

Timothy M. Cox, Guillermo Drelichman, Renata Cravo et al. · Blood · 2017 · 92 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +9

Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil

Cirley Maria de Oliveira Lobato, Liana Codés, Giovanni Faria Silva et al. · Annals of Hepatology · 2019 · 40 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil

Roberto Focaccia, D.C.M. Baraldo, Maria Lúcia Gomes Ferraz et al. · The Brazilian Journal of Infectious Diseases · 2004 · 38 citations · Full text

Medicine, Health Sciences, Infectious Diseases +17

MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection

Siumara Túlio, Fábio R. Faucz, Renata Iani Werneck et al. · Human Immunology · 2011 · 35 citations · Full text

Medicine, Genetics, Molecular Genetics +9

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?

Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lúcia Alves Pedroso · Archives of Endocrinology and Metabolism · 2017 · 35 citations · Full text

Medicine, Endocrinology, Pathology +17